Found 9 results
Filters: Keyword is Blotting, Western  [Clear All Filters]
2017
Mondello P, Derenzini E, Asgari Z, Philip J, Brea EJ, Seshan V, Hendrickson RC, de Stanchina E, Scheinberg DA, Younes A.  2017.  Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.. Oncotarget. 8(8):14017-14028.
Bhattacharya S, Yin J, Winborn CS, Zhang Q, Yue J, Chaum E.  2017.  Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment Epithelium.. Invest Ophthalmol Vis Sci. 58(4):2366-2387.
2016
Woods CA, Guttman ZR, Huang D, Kolaric RA, Rabinowitsch AI, Jones KT, S de Vaca C, Sclafani A, Carr KD.  2016.  Insulin receptor activation in the nucleus accumbens reflects nutritive value of a recently ingested meal.. Physiol Behav. 159:52-63.
Zhang Y, Seeburg DP, Pulli B, Wojtkiewicz GR, Bure L, Atkinson W, Schob S, Iwamoto Y, Ali M, Zhang W et al..  2016.  Myeloperoxidase Nuclear Imaging for Epileptogenesis.. Radiology. 278(3):822-30.
Neel VA, Todorova K, Wang J, Kwon E, Kang M, Liu Q, Gray N, Lee SW, Mandinova A.  2016.  Sustained Akt Activity Is Required to Maintain Cell Viability in Seborrheic Keratosis, a Benign Epithelial Tumor.. J Invest Dermatol. 136(3):696-705.
2015
Korb E, Herre M, Zucker-Scharff I, Darnell RB, C Allis D.  2015.  BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice.. Nat Neurosci. 18(10):1464-73.
2014
Rampal R, Ahn J, Abdel-Wahab O, Nahas M, Wang K, Lipson D, Otto GA, Yelensky R, Hricik T, McKenney ASophia et al..  2014.  Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.. Proc Natl Acad Sci U S A. 111(50):E5401-10.
2012
Forghani R, Wojtkiewicz GR, Zhang Y, Seeburg D, Bautz BRM, Pulli B, Milewski AR, Atkinson WL, Iwamoto Y, Zhang ER et al..  2012.  Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.. Radiology. 263(2):451-60.
2011
Wei H-J, Wu ATH, Hsu C-H, Lin Y-P, Cheng W-F, Su C-H, Chiu W-T, Whang-Peng J, Douglas FL, Deng W-P.  2011.  The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine.. Mol Ther. 19(12):2249-57.